Descrizione del progetto
Un metodo innovativo e rapido per rilevare la legionella
I batteri Legionella pneumophila vengono generalmente rilevati dalla tradizionale coltura microbiologica che richiede fino a 14 giorni per produrre un risultato. Alcune metodologie recenti hanno ridotto i tempi di test a tre giorni, ma queste richiedono l’esecuzione di due o tre test, come pure un investimento considerevole in attrezzatura specializzata. Il progetto Bio-LP-1, finanziato dall’UE, propone un metodo diagnostico pionieristico sulla base di tecnologie molecolari che forniscono un’identificazione completa dell’agente patogeno della Legionella a livello dei sierotipi con un unico test. Il metodo richiede meno tempo per produrre risultati e offre informazioni più solide; inoltre, richiede un minor tempo di preparazione e non richiede attrezzature specializzate, il che genera notevoli risparmi sui costi.
Obiettivo
Traditional microbiological culture for Legionella bacteria takes up to 14 days to provide a result. While some rapid methodologies have been developed they require 2-3 tests to be completed meaning it can take 3 days for a result and they also require capital investments in costly specialised equipment.
Bio-LP-1 is a novel rapid test which has the capacity to transform the environmental global testing landscape for the human pathogen Legionella.
Bio-LP-1’s unique selling point is that it provides a complete identification of Legionella to the serogroup level in a single test using molecular technologies.
This is a diagnostic breakthrough, as all existing competitors can only offer 2 or 3 stage molecular tests to generate the equivalent result. The single test Bio-LP-1 product format is 5 x FASTER than the nearest competitor, Offers €319,200 pa savings for large test laboratories conducting at least 50,000 tests per year. Bio-LP-1 – offers a faster time to result; yields more robust information; requires less hands on time; requires no specialised equipment and ultimately has the potential for significant cost savings.
Current estimates predict that the global legionella testing market will reach $352.6 million by 2025 and that the water testing market is the fastest growing sector.
We have a best in class consortium:
BPD - European experts in development and commercialisation of rapid microbial diagnostic solutions.
myPOLs - leader in molecular biology reagent manufacturing.
Genaxxon - European leader in sales of innovative molecular IVD products)
Control Microbiológico - ENAC accredited large environmental testing laboratory.)
BPD and myPOLS have previously collaborated in the development of Bio-Lp-1, over past 12 months to bring Bio-LP-1 to TRL 6
Campo scientifico
Parole chiave
Programma(i)
Argomento(i)
Meccanismo di finanziamento
IA - Innovation actionCoordinatore
CO WATERFORD
Irlanda
L’organizzazione si è definita una PMI (piccola e media impresa) al momento della firma dell’accordo di sovvenzione.